Literature DB >> 23830363

Clinicopathologic characteristics of colonic carcinoid tumors.

Sara E Murray1, Ricardo V Lloyd, Rebecca S Sippel, Herbert Chen.   

Abstract

BACKGROUND: Extra-appendiceal colonic carcinoids are uncommon neuroendocrine tumors with a poor prognosis compared with carcinoids of other gastrointestinal origins. Few studies have examined the clinicopathologic profile and behavior of this rare tumor.
MATERIALS AND METHODS: A retrospective analysis was performed on patients with colonic carcinoid tumors evaluated at a single tertiary care center between 1996 and 2012. Collected data included patient and tumor characteristics, presentation, treatment, recurrence, and survival. Results were integrated into a comprehensive review of the colonic carcinoid literature.
RESULTS: In total, 114 patients with colorectal carcinoid tumors were identified, and 15 patients with extra-appendiceal tumors were analyzed. The mean age was 58.6 ± 3.0 y, and subjects were predominantly male (73.3%). The most common presenting problem was abdominal pain (33.3%), although 26.7% of patients were asymptomatic. Cecal tumors were the most prevalent (73.3%), and most patients underwent right hemicolectomy. Three patients with lesions < 1 cm were treated endoscopically. The mean tumor diameter was 2.9 ± 0.5 cm, with lymph node or distant metastasis present in 53.3% and 26.7%, respectively. All but two patients underwent a presumed curative resection. During a mean follow-up of 4.2 ± 1.0 y, there was only one death (non-carcinoid specific). Eleven patients were alive without evidence of disease at last follow-up and three patients were alive with disease, one of whom initially had a presumed curative resection that recurred.
CONCLUSIONS: This case series further elucidates the clinicopathologic characteristics of colonic carcinoid tumors, which aids physicians in guiding the diagnosis and management of these rare tumors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinoid; Clinicopathologic; Colon; Extra-appendiceal; Neuroendocrine

Mesh:

Substances:

Year:  2013        PMID: 23830363      PMCID: PMC3759590          DOI: 10.1016/j.jss.2013.05.107

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

1.  Colonic carcinoid tumors: a clinicopathologic study of 23 patients from a single institution.

Authors:  Daniel Reis Waisberg; Antonio Sergio Fava; Lourdes Conceição Martins; Leandro Luongo Matos; Maria Isete Fares Franco; Jaques Waisberg
Journal:  Arq Gastroenterol       Date:  2009 Oct-Dec

2.  Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry.

Authors:  G H Ballantyne; P E Savoca; J T Flannery; M H Ahlman; I M Modlin
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

3.  Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells.

Authors:  Muthusamy Kunnimalaiyaan; Kelly Traeger; Herbert Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-10       Impact factor: 4.052

4.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

5.  Carcinoid tumors of the gastrointestinal tract: a 44-year experience.

Authors:  S Saha; S Hoda; R Godfrey; C Sutherland; K Raybon
Journal:  South Med J       Date:  1989-12       Impact factor: 0.954

6.  Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.

Authors:  David Yu Greenblatt; Max Cayo; Li Ning; Renata Jaskula-Sztul; Megan Haymart; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  J Gastrointest Surg       Date:  2007-09-15       Impact factor: 3.452

7.  Colon carcinoid tumors. A population-based study.

Authors:  C Spread; H Berkel; L Jewell; H Jenkins; W Yakimets
Journal:  Dis Colon Rectum       Date:  1994-05       Impact factor: 4.585

Review 8.  Carcinoid tumors of the gut. Our experience over three decades and review of the literature.

Authors:  J B Marshall; G Bodnarchuk
Journal:  J Clin Gastroenterol       Date:  1993-03       Impact factor: 3.062

9.  Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.

Authors:  Dik J Kwekkeboom; Wouter W de Herder; Boen L Kam; Casper H van Eijck; Martijn van Essen; Peter P Kooij; Richard A Feelders; Maarten O van Aken; Eric P Krenning
Journal:  J Clin Oncol       Date:  2008-05-01       Impact factor: 44.544

10.  Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group.

Authors:  J Maroun; W Kocha; L Kvols; G Bjarnason; E Chen; C Germond; S Hanna; P Poitras; D Rayson; R Reid; J Rivera; A Roy; A Shah; L Sideris; L Siu; R Wong
Journal:  Curr Oncol       Date:  2006-04       Impact factor: 3.677

View more
  4 in total

1.  Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs.

Authors:  Xiaoling Duan; Man Zhao; Shenglei Zhang; Zhibin Xu; Lili Mi; Jianfei Shi; Xiaoying Ma; Yueping Liu; Ning Li; Xiaolei Yin; Xin Han; Guangjie Han; Jinfeng Wang; Jinsheng Xu; Fei Yin
Journal:  Int J Colorectal Dis       Date:  2020-04-20       Impact factor: 2.571

2.  Intestinal occlusion by stenotic neuroendocrine tumours of left colon and concomitant association with small bowel gastrointestinal stromal tumours: A case report.

Authors:  M Amoruso; V Papagni; A Picciariello; V L Pinto; D D'Abbicco; A Margari
Journal:  Int J Surg Case Rep       Date:  2018-10-26

3.  Analysis of the Incidence and Clinical Features of Colorectal Nonadenocarcinoma in Korea: A National Cancer Registry-Based Study.

Authors:  Soomin Nam; Dongwook Kim; Kyuwon Jung; Yoon Jung Choi; Jung Gu Kang
Journal:  Ann Coloproctol       Date:  2020-05-15

4.  Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections.

Authors:  Osayande Osagiede; Elizabeth Habermann; Courtney Day; Emmanuel Gabriel; Amit Merchea; Riccardo Lemini; Iktej S Jabbal; Dorin T Colibaseanu
Journal:  J Gastrointest Oncol       Date:  2020-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.